agilon health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of agilon health generated cash of -$156,199,000, which is less than the previous year. Cash used in financing activities reached the amount of -$193,133,000 last year. Net change in cash is therefore -$361,583,000.
Cash Flow
| 2019 | -103.86M | -5.06M | 176.29M |
|---|---|---|---|
| 2020 | -53.20M | 22.06M | 24.62M |
| 2021 | -148.15M | -90.50M | 1.15B |
| 2022 | -130.80M | -444.38M | 28.05M |
| 2023 | -156.19M | -44.01M | -193.13M |
AGL Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 475.91M | 1.05B | 139.09M | 145.61M | 78.23M |
Operating activities | |||||
Net income | -262.80M | -106.86M | -406.78M | -60.05M | -282.74M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 20.16M | 13.77M | 14.67M | 14.09M | 41.41M |
Stock-based compensation expense | 69.49M | 28.38M | 292.39M | 6.68M | 5.22M |
| Deferred income tax benefit | 69.49M | 28.38M | 292.39M | 6.68M | 5.22M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | -204.16M | -149.04M | -59.38M | -23.28M |
Inventories | 0 | 204.16M | 149.04M | 0 | 0 |
Accounts payable | 473.61M | 173.44M | 95.69M | 67.30M | 38.26M |
Cash generated by operating activities | -156.19M | -130.80M | -148.15M | -53.20M | -103.86M |
Investing activities | |||||
Purchases Of Investments | -114.65M | -458.26M | -7.09M | -2.05M | 0 |
Investments In Property Plant And Equipment | -15.83M | -32.66M | -13.42M | -2.35M | -3.90M |
Acquisitions Net | -43.05M | 500K | -1.34M | 26.20M | 0 |
Cash generated by investing activities | -44.01M | -444.38M | -90.50M | 22.06M | -5.06M |
Financing activities | |||||
Common Stock Issued | 11.86M | 33.05M | 1.18B | 33.59M | 180.19M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -200M | 0 | 0 | -6.74M | 0 |
Repayments of term debt | -5M | -5M | -19.89M | -3.04M | -3.59M |
Cash used in financing activities | -193.13M | 28.05M | 1.15B | 24.62M | 176.29M |
Net Change In Cash | -361.58M | -547.14M | 915.72M | -6.51M | 67.37M |
Cash at end of period | 114.32M | 507.68M | 1.05B | 139.09M | 145.61M |
| Data source | Data source | Data source |